Cipla has strengthened its respiratory leadership bench with the appointment of Rahul Awari as Head of Marketing – Cipla Respiratory (Associate Director). The move comes after Awari’s stint steering the company’s cardiology and inhalation portfolios, and it places one of pharma marketing’s more experienced hands at the helm of one of Cipla’s flagship therapy areas.
Announcing the elevation on LinkedIn, Awari expressed his gratitude to senior leadership for their guidance through the years, naming Pijus Mukhopadhyay, Arijit Choudhury, Rajpal Rana, Srirup Sircar and Darshan Shaha among those who shaped his journey. He said he is looking forward to driving strategic growth, innovation and better patient outcomes in respiratory care, an area Cipla has long treated as central to its identity in the Indian pharmaceutical market.
Awari’s rise to this role has been anything but sudden. He has spent more than eight years at Cipla, working across respiratory, cardiology and ophthalmology in a series of increasingly senior marketing positions. Most recently, he served as group brand manager for the company’s respiratory inhalation portfolio, giving him a close, ground level understanding of the very business he now leads.
Before that, his work on Cipla’s heart failure portfolio left a measurable mark. He played a key role in strengthening the company’s position in loop diuretics and secondary prevention therapies, helping lift market share in loop diuretics from 70 per cent to 73 per cent through carefully designed, therapy shaping initiatives. It is the kind of number that tends to catch a boardroom’s attention, and one that likely factored into his elevation now.
His career in pharmaceutical marketing runs deeper still, spanning more than sixteen years across some of India’s best-known names in the sector. Before joining Cipla, Awari built his expertise at FDC Limited, Entod Pharmaceuticals, GSK Pharmaceuticals and Wockhardt, moving across ophthalmology, respiratory and broader pharmaceutical portfolios along the way. That breadth of exposure across therapy areas is unusual, and it gives him a wider lens than most marketers stepping into a respiratory leadership role.
Awari holds a Bachelor of Pharmacy degree from Dr D. Y. Patil Institute of Pharmaceutical Science, Pune, affiliated with the University of Pune, a grounding in the science that has clearly stayed with him through a career built on translating clinical value into market performance.
With respiratory care remaining one of Cipla’s flagship therapy areas in a fiercely competitive market, the appointment is a clear signal of intent. It reflects the company’s continued focus on strengthening its leadership bench from within, rewarding depth of experience over external hires, and backing marketers who understand the science as well as the strategy behind it.
Congratulations to Rahul Awari on a well-earned step up.
